Treatment for Erectile Dysfunction
Patients receiving penile prostheses should be instructed in the operation
- Diabetes management
- High blood pressure control
- Cholesterol lowering
- Avoiding drug abuse
- Limiting sedentary lifestyle
- Regular health screenings
- Treating hormonal disorders
- Managing autoimmune conditions
- Reducing obesity risks
- Avoiding smoking and alcohol
- Prostate health maintenance
of the prosthesis before surgery and again in the postoperative period.
| Medication | Contraindications | Common Risks |
|---|---|---|
| Sildenafil | Nitrate use, severe cardiac conditions | Hypotension, headache, visual disturbances |
| Tadalafil | Severe liver or kidney disease, recent stroke | Back pain, muscle aches, gastric reflux |
| Vardenafil | Certain antibiotics or antifungals affecting CYP3A4 | Dizziness, flushing |
| Alprostadil (injection) | Bleeding disorders, penile implants in place | Pain, fibrosis at injection site |
The prosthesis usually is not activated until approximately 6 weeks after surgery, so as to allow the edema and pain to subside.
Surgery & Shockwave Treatment for Erectile Dysfunction
[43] Heruti et al recommended that in adult male patients, ED should be considered when a sleep disorder—especially sleep apnea syndrome—is suspected, and vice versa. Hypogonadism that results in low testosterone levels adversely affects libido and erectile function. Hypothyroidism is a very rare cause of ED. Peyronie disease may result in fibrosis and curvature of the penis. Men with severe Peyronie disease may have enough scar tissue in the corpora to impede blood flow.
Dana Alan Ohl, MD
Mental health disorders, particularly depression, are likely to affect sexual performance. The MMAS data indicate an odds ratio of 1.82 for men with depression. Other associated factors, both cognitive and behavioral, may contribute. In addition, ED alone can induce depression. Cosgrove et al reported a higher rate of sexual dysfunction in veterans with posttraumatic stress disorder (PTSD) than in veterans who did not develop this problem.
4.3 Low-intensity extracorporeal shock wave therapy (Li-ESWT)
[45] The domains on the International Index of Erectile Function (IIEF) questionnaire that demonstrated the most change included overall sexual satisfaction and erectile function. [46, 47] Men with PTSD should be evaluated and treated if they have sexual dysfunction. Prostate surgery for benign prostatic hyperplasia has been documented to be associated with ED in 10-20% of men. This association is thought to be related to nerve damage from cauterization. Newer procedures (eg, microwave, laser, or radiofrequency ablation) have rarely been associated with ED. The prosthesis is checked in the office before the patient begins to use it.
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Kamagra Gold | 100 mg | 12 Pills | 55.64€ 52.99€ | |
| Cialis Professional | 20mg | 90 + 2 Pills | 241.49€ 229.99€ | |
| Cialis Soft Tabs | 20mg | 30 + 4 Pills | 87.43€ 83.27€ | |
| Levitra Generic | 20mg | 90 + 8 Pills | 180.78€ 172.17€ | |
| Kamagra 100 mg | 100 mg | 20 Pills | 86.09€ 81.99€ | |
| Priligy Generic Dapoxetine | 60mg | 90 + 10 Pills | 265.64€ 252.99€ | |
| Viagra Super Active | 100mg | 60 + 8 Pills | 116.84€ 111.28€ | |
| Levitra Soft Tabs | 20mg | 90 + 6 Pills | 241.31€ 229.82€ | |
| Cialis Generic | 20mg | 180 + 10 Pills | 254.09€ 241.99€ | |
| Levitra Professional | 20mg | 120 + 4 Pills | 348.44€ 331.85€ | |
| Cialis Super Active | 20mg | 120 + 16 Pills | 382.15€ 363.95€ | |
| Super Kamagra | 160 mg | 32 + 4 Pills | 218.25€ 207.86€ | |
| Levitra Generic | 20mg | 120 + 10 Pills | 224.15€ 213.48€ | |
| Levitra Soft Tabs | 20mg | 120 + 8 Pills | 288.52€ 274.78€ | |
| Levitra Original | 20mg | 8 Pills | 65.05€ 61.95€ | |
| Kamagra Soft Tabs | 100mg | 120 + 6 Pills | 311.78€ 296.93€ | |
| Cialis Generic | 2.5mg | 20 Pills | 40.73€ 38.79€ |
For patient education information, see
P-Shot® PRP Therapy for Sexual Performance
This educational process allows a review of the basic aspects of the anatomy and physiology of the sexual response and an explanation of the possible etiology and associated risk factors (eg, smoking and the use of various medications). Treatment options and their benefits and risks should be discussed. This type of dialogue allows the patient and physician to cooperate in developing an optimal management strategy. Patients with both ED and cardiovascular disease who receive treatment with an oral PDE5 inhibitor require education regarding what to do if anginal episodes develop while the drug is in their system. Such education includes stressing the importance of alerting emergency care providers to the presence of the drug so that nitrate treatment is avoided. the Erectile Dysfunction Health Center
- Medications for ED are available by prescription and should be used safely.
- A balanced diet rich in fruits, vegetables, and whole grains supports heart health.
- Addressing relationship issues can reduce performance pressure.
- Alternative medicine approaches include herbal remedies, though evidence varies.
- Increased physical activity boosts nitric oxide production, aiding erections.
- Hormonal evaluation helps determine if testosterone therapy is appropriate.
- Caring for mental health reduces psychological barriers to sexual function.
Although ED is common, you don’t have to live with it.
Related Links
In addition, the risk of ED was not increase in 12 346 men prescribed finasteride 1 mg for alopecia, compared with unexposed men with alopecia (OR 0.95). The risk of ED did increase with longer duration of BPH, regardless of drug exposure. Exercise and lifestyle modifications may improve erectile function. Weight loss sex tablet for women may help by decreasing inflammation, increasing testosterone, and improving self-esteem. Patients should be educated to increase activity, reduce weight, and stop smoking, as these efforts can improve or restore erectile function in men without comorbidities.
Shockwave Therapy
Precise glycemic control in diabetic patients and pharmacologic treatment of hypertension may be important in preventing or reducing sexual dysfunction. Cigarette smoking has been shown to be an independent risk factor. In studies evaluating more than 6000 men, the risk of developing ED increased by a factor of 1.5. Sexual dysfunction is highly prevalent in men and women. In the MMAS, 52% of the respondents reported some degree of erectile difficulty.
Evaluation and Diagnosis
Complete ED, defined as (1) the total inability to obtain or maintain an erection during sexual stimulation and (2) the absence of nocturnal erections, occurred in 10% of the respondents. Mild and moderate ED occurred in 17% and 25% of responders, respectively. Although the rate of mild ED in the MMAS remained constant (17%) in men aged 40-70 years, the number of men reporting moderate ED doubled (17-34%) and the number of men reporting complete ED tripled (5-15%). If the MMAS data are extrapolated to the US population, an estimated 18-30 million men are affected by ED. In the National Health and Social Life Survey (NHSLS), a nationally representative probability sample of men and women aged 18-59 years, 10.4% of men reported being unable to achieve or maintain an erection during the past year. Our urological specialists understand your hesitation and frustration.
| Therapy | Description | Status |
|---|---|---|
| Low-Intensity Shockwave Therapy | Promotes blood vessel regeneration | Experimental/clinics |
| Stem Cell Therapy | Regenerates damaged tissues in penis | Experimental |
| Platelet-Rich Plasma (PRP) | Uses patient's blood to improve tissue healing | Experimental |
| Gene Therapy | Targets genetic causes of ED | Under research |
We offer a range of personalized treatments
Erectile dysfunction may be caused by the following conditions:
[54] There is a striking correlation with the proportion of men in the MMAS who reported complete ED. Studies conducted around the world report similar risk factors and similar prevalence rates for ED. All studies demonstrate a strong association with age, even when data are adjusted for the confounding effects of other risk factors. The independent association with aging suggests that vascular changes in the arteries and sinusoids of the corpora cavernosa, similar to those found elsewhere in the body, are contributing factors. Other risk factors associated with aging include depression, sleep apnea, and low HDL levels.
Reduce smoking and alcohol intake
Long-term predictions based on an aging population and an increase in risk factors (eg, hypertension, diabetes, vascular disease, pelvic and prostate surgery, benign prostatic hyperplasia, and lower urinary tract symptoms) suggest a large increase in the number of men with ED. In addition, the prevalence of ED is underestimated because physicians frequently do not question their patients about this disorder. In a prospective population-based study of 1709 men aged 40-70 years, Araujo et al found that ED was significantly associated with increased all-cause mortality. [57] The increase primarily resulted from cardiovascular mortality. In a prospective study from the Prostate Cancer Prevention Trial database, Thompson et al reported that men presenting with ED had a significantly higher chance of developing a cardiovascular event over a 7-year follow-up period.
Traditional ED medications
[58] The hazard ratio was 1.45, which is in the range of risk associated with current smoking or a family history of MI. An analysis of 14 studies involving more than 90,000 patients with ED confirmed the relation between ED and an increased risk of cardiovascular events and mortality. [59] Compared with patients without ED, those with ED had a 44% increased risk of cardiovascular events, a 25% increased risk of all-cause mortality, a 62% increased risk of MI, and a 39% increased risk of cerebrovascular events. Treatment of ED, either through lifestyle interventions or by pharmacologic means, may improve prognosis and reduce risk. Associated morbidity may include various other male sexual dysfunctions, such as premature (early) ejaculation and male hypoactive sexual desire disorder. to help you achieve the sexual function
When to See a Doctor
Radical prostatectomy for the treatment of prostate cancer poses a significant risk of ED. A number of factors are associated with the chance of preserving erectile function. If both nerves that course on the lateral edges of the prostate can be saved, the chance of maintaining erectile function is reasonable. The odds depend on the age of the patient. Men younger than 60 years have a 75-80% chance of preserving potency, but men older than 70 years have only a 10-15% chance.
Tools & Resources
The Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) study, designed to determine whether an individual man’s sexual outcomes after most common treatments for early-stage prostate cancer could be accurately predicted on the basis of baseline characteristics and treatment plans, found that 2 years after treatment, 177 (35%) of 511 men who underwent prostatectomy reported the ability to attain functional erections suitable for intercourse. In comparison, 37% of men who had received external radiotherapy as their primary therapy reported the ability to attain functional erections suitable for intercourse, along with 43% of men who had received brachytherapy as primary treatment. Pretreatment sexual health-related quality of life score, age, serum prostate-specific antigen (PSA) level, race or ethnicity, body mass index, and intended treatment details were associated with functional erections 2 years after treatment. After surgery, one of the oral PDE5 inhibitors (sildenafil, vardenafil, or tadalafil) is frequently used to assist in the recovery of erectile function. The benefit of penile rehabilitation therapy is under investigation, but results have been mixed.
5 Best Treatments for ED
ED is an adverse effect of many commonly prescribed medications. For example, some psychotropic drugs and antihypertensive agents are associated with ED. Persistent posttreatment ED is a listed adverse effect of the 5-alpha reductase inhibitors finasteride and dutasteride and of alpha blockers. However, a review of a United Kingdom medical record database found no evidence that the use of 5-alpha reductase inhibitors independently increase the risk for ED. In 71,849 men with benign prostatic hyperplasia (BPH), the risk of ED was not increased with the use of finasteride or dutasteride only (odds ratio [OR] 0.94), or a 5-alpha reductase inhibitor plus an alpha blocker (OR 0.92) compared with an alpha blocker only. you want: The Food and Drug Administration
| Procedure | Description | Risks |
|---|---|---|
| Penile Implants | Inflatable or semi-rigid devices implanted in penis | Infection, mechanical failure |
| Vascular Surgery | Repairs or bypasses blood vessels in penis | Usually for younger men with vascular disease |
| Penile Artery Revascularization | Restores blood flow in specific cases | Limited success, specialized procedure |
(FDA) has approved three medicines for ED.
Treatment for Erectile Dysfunction
The NHSLS found that 28.5% of men aged 18-59 years reported premature ejaculation, and 15.8% lacked sexual interest during the past year. An additional 17% reported anxiety about sexual performance, and 8.1% had a lack of pleasure in sex. Men with ED may also experience anxiety or depression [60] . Erectile disorder is common in men with lower urinary tract symptoms related to BPH. The laboratory results should be discussed with the patient and, if possible, with his sexual partner.